An international research team led by UMC Utrecht has developed two groundbreaking antibodies that can inhibit inflammation associated with autoimmune diseases. These innovative antibodies...
Roche’s cancer drug, Gazyva, has received approval from the U.S. Food and Drug Administration (FDA) for the treatment of adults with active lupus nephritis,...